Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;19(1):e202100712.
doi: 10.1002/cbdv.202100712. Epub 2021 Dec 16.

Homology Modeling and Molecular Dynamics Simulations of Trypanosoma cruzi Phosphodiesterase b1

Affiliations

Homology Modeling and Molecular Dynamics Simulations of Trypanosoma cruzi Phosphodiesterase b1

Manuel A Llanos et al. Chem Biodivers. 2022 Jan.

Abstract

Cyclic nucleotide phosphodiesterases have been implicated in the proliferation, differentiation and osmotic regulation of trypanosomatids; in some trypanosomatid species, they have been validated as molecular targets for the development of new therapeutic agents. Because the experimental structure of Trypanosoma cruzi PDEb1 (TcrPDEb1) has not been solved so far, an homology model of the target was created using the structure of Trypanosoma brucei PDEb1 (TbrPDEb1) as a template. The model was refined by extensive enhanced sampling molecular dynamics simulations, and representative snapshots were extracted from the trajectory by combined clustering analysis. This structural ensemble was used to develop a structure-based docking model of the target. The docking accuracy of the model was validated by redocking and cross-docking experiments using all available crystal structures of TbrPDEb1, whereas the scoring accuracy was validated through a retrospective screen, using a carefully curated dataset of compounds assayed against TbrPDEb1 and/or TcrPDEb1. Considering the results from in silico validations, the model may be applied in prospective virtual screening campaigns to identify novel hits, as well as to guide the rational design of potent and selective inhibitors targeting this enzyme.

Keywords: Chagas disease; Trypanosoma cruzi; homology modeling; molecular docking; molecular dynamics; phosphodiesterase.

PubMed Disclaimer

References

    1. K. C. F. Lidani, F. A. Andrade, L. Bavia, F. S. Damasceno, M. H. Beltrame, I. J. Messias-Reason, T. L. Sandri, ‘Chagas Disease: From Discovery to a Worldwide Health Problem’, Front. Public Health 2019, 7, 166.
    1. C. A. Morillo, J. A. Marin-Neto, A. Avezum, S. Sosa-Estani, A. Rassi, F. Rosas, E. Villena, R. Quiroz, R. Bonilla, C. Britto, F. Guhl, E. Velazquez, L. Bonilla, B. Meeks, P. Rao-Melacini, J. Pogue, A. Mattos, J. Lazdins, A. Rassi, S. J. Connolly, S. Yusuf, ‘Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy’, N. Engl. J. Med. 2015, 373, 1295-1306.
    1. M. Vallejo, P. P. Reyes, M. M. Garcia, A. G. G. Garay, ‘Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection)’, Cochrane Database Syst. Rev. 2020, DOI 10.1002/14651858.CD004102.pub3.
    1. G. D. Alonso, A. C. Schoijet, H. N. Torres, M. M. Flawiá, ‘TcrPDEA1, a cAMP-specific phosphodiesterase with atypical pharmacological properties from Trypanosoma cruzi’, Mol. Biochem. Parasitol. 2007, 152, 72-79.
    1. Y. Shakur, H. P. de Koning, H. Ke, J. Kambayashi, T. Seebeck, ‘Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases’, Handb. Exp. Pharmacol. 2011, 487-510.

MeSH terms

Substances

LinkOut - more resources